| __timestamp | Protagonist Therapeutics, Inc. | Verona Pharma plc |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 4101058 |
| Thursday, January 1, 2015 | 11831000 | 10763215 |
| Friday, January 1, 2016 | 25705000 | 5579049 |
| Sunday, January 1, 2017 | 46181000 | 32051299 |
| Monday, January 1, 2018 | 59497000 | 24482286 |
| Tuesday, January 1, 2019 | 65003000 | 43892589 |
| Wednesday, January 1, 2020 | 74506000 | 44505000 |
| Friday, January 1, 2021 | 126006000 | 79406000 |
| Saturday, January 1, 2022 | 126215000 | 49283000 |
| Sunday, January 1, 2023 | 120161000 | 17282730 |
Unlocking the unknown
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Protagonist Therapeutics, Inc. and Verona Pharma plc have demonstrated contrasting approaches to R&D investment.
From 2014 to 2023, Protagonist Therapeutics consistently outpaced Verona Pharma in R&D spending, with a peak in 2022 where their investment was nearly 160% higher than Verona's. This trend highlights Protagonist's aggressive strategy in advancing their therapeutic pipeline. In contrast, Verona Pharma's R&D expenses peaked in 2021, showing a more conservative approach.
Despite these differences, both companies have shown a commitment to innovation, with Verona Pharma increasing its R&D spending by over 300% from 2014 to 2021. As the biotech landscape evolves, these spending patterns may offer insights into each company's future growth and market positioning.
AbbVie Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
United Therapeutics Corporation vs Protagonist Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Neurocrine Biosciences, Inc. and Verona Pharma plc
Comparing Innovation Spending: Intra-Cellular Therapies, Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Insmed Incorporated and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for BioMarin Pharmaceutical Inc. and Protagonist Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Verona Pharma plc
Research and Development Expenses Breakdown: Grifols, S.A. vs Verona Pharma plc
Research and Development: Comparing Key Metrics for Alkermes plc and Protagonist Therapeutics, Inc.
R&D Insights: How Verona Pharma plc and Xenon Pharmaceuticals Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Verona Pharma plc and Viridian Therapeutics, Inc.
R&D Insights: How Protagonist Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Allocate Funds